The results derived from this study will not only improve our understanding of the mechanisms associated with the action of ezrin in regulating the inflammatory reaction in pulmonary alveolar epithelial cells, but also offers an opportunity to target ezrin when developing novel therapies for the management of ALI/ARDS. Here, EZR is linked to acute respiratory distress syndrome.